Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inmune Bio Inc (NQ: INMB ) 6.150 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inmune Bio Inc < Previous 1 2 3 4 5 Next > INmune Bio's Return On Capital Employed Insights March 09, 2022 INmune Bio (NASDAQ:INMB) brought in sales totaling $163.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 2.25%, resulting in a loss of... Via Benzinga INmune Bio: Q4 Earnings Insights March 03, 2022 INmune Bio (NASDAQ:INMB) reported its Q4 earnings results on Thursday, March 3, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings INmune... Via Benzinga The Daily Biotech Pulse: NuCana Shelves Biliary Tract Cancer Study, Tricida Data Readout Pushed Back Due to Ukrainian Crisis, Synlogic Names New CFO March 03, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus NuCana Discontinues Biliary Tract Cancer Study Following Futility Analysis... Via Benzinga The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight February 27, 2022 Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first... Via Benzinga Earnings Scheduled For March 3, 2022 March 03, 2022 Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million. • Urban... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session February 18, 2022 Gainers Biofrontera (NASDAQ:BFRA) stock moved upwards by 11.8% to $3.49 during Friday's pre-market session. The market value of their outstanding shares is at $98.9... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session February 17, 2022 Gainers NeuroOne Medical Tech (NASDAQ:NMTC) shares moved upwards by 12.3% to $3.0 during Thursday's pre-market session. The company's market cap stands at $48.5... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session February 09, 2022 Gainers Nuwellis (NASDAQ:NUWE) stock moved upwards by 13.6% to $1.25 during Wednesday's pre-market session. The market value of their outstanding shares is at $13.1... Via Benzinga INmune Bio, Inc. (INMB) Q3 2021 Earnings Call Transcript November 04, 2021 INMB earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial 92 Biggest Movers From Friday November 08, 2021 Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session October 25, 2021 Gainers Jaguar Health (NASDAQ:JAGX) shares increased by 14.64% to $2.08 during Monday's regular session. The current volume of 7.2 million shares is 300.39% of Jaguar... Via Benzinga Why Cortexyme Thinks It Could Be Next In The Mega Alzheimer's Drug Market October 21, 2021 Cortexyme is testing a twice-day pill to treat Alzheimer's disease. Via Investor's Business Daily Inmune Bio Stock Flashes Robust RS Rating September 22, 2021 On Wednesday, Inmune Bio stock saw its Relative Strength Rating jump into the 90-plus percentile, to 92 from 85 the day before. Via Investor's Business Daily 12 Health Care Stocks Moving In Wednesday's Intraday Session September 08, 2021 Gainers Kadmon Holdings (NASDAQ:KDMN) shares increased by 72.64% to $9.15 during Wednesday's regular session. Trading volume for Kadmon Holdings's stock is 95.3... Via Benzinga 54 Biggest Movers From Yesterday September 09, 2021 Gainers eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR) shares jumped 111.8% to settle at $27.17 on Wednesday after jumping 50% on Tuesday. Helbiz, Inc. (NASDAQ: HLBZ) gained 84% to... Via Benzinga 30 Stocks Moving In Wednesday's Mid-Day Session September 08, 2021 Gainers Kadmon Holdings, Inc. (NASDAQ: KDMN) shares jumped 72.6% to $9.15. Sanofi announced Wednesday it has agreed to acquire New York-based biopharma Kadmon in a $1.9 billion... Via Benzinga The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod September 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc... Via Benzinga Exposures Product Safety The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week September 05, 2021 Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday... Via Benzinga 46 Stocks Moving In Thursday's Mid-Day Session September 02, 2021 Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 36% to $9.02 as traders circulate a tweet from popular Twitter trader Will Meade saying 'Long $ANY this is the next $SPRT... Via Benzinga INmune Bio Stock Pops As Small-Cap Shows Promise In Alzheimer's Disease September 02, 2021 INmune Bio said its experimental Alzheimer's drug improved markers of inflammation in the brain, and INMB stock popped Thursday. Via Investor's Business Daily 12 Health Care Stocks Moving In Thursday's Pre-Market Session September 02, 2021 Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 22.1% to $2.32 during Thursday's pre-market session. The company's market cap stands at $28.0 million.... Via Benzinga The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab September 02, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV... Via Benzinga Exposures COVID-19 Product Safety 28 Stocks Moving in Thursday's Pre-Market Session September 02, 2021 Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 39.7% to $26.93 in pre-market trading after jumping 278% on Wednesday. Focus Universal recently priced 2 million shares at $5 per... Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session September 01, 2021 Gainers INmune Bio (NASDAQ:INMB) shares ... Via Benzinga Why Are Shares Of INmune Bio Trading Higher Wednesday Afternoon? September 01, 2021 INmune Bio, Inc. (NASDAQ: INMB) shares traded higher Wednesday afternoon following data out of a trial for the company's Alzheimer's drug candidate. The company said its... Via Benzinga 10 Stocks Moving In Wednesday's After-Hours Session September 01, 2021 Gainers INmune Bio (NASDAQ: INMB) shares are trading higher after the company announced XPro has been found to decrease multiple species of Phospho Tau and improve neuroimaging... Via Benzinga The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In A Light Week August 29, 2021 Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. and BioNTech SE. The stocks subsequently moved back and... Via Talk Markets The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week August 29, 2021 Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (... Via Benzinga INmune Bio Stock Jumps On Promising Biomarker Data From Early-Stage Blood Cancer Trial August 26, 2021 INmune Bio Inc (NASDAQ: INMB) announced that the first patient who received INKmune has successfully shown NK activation and functional differentiation. INKmune is... Via Benzinga The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO August 26, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... Via Benzinga Exposures COVID-19 < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.